Skip to main content
CDC Website

Information Sheet

Targeted Tuberculin Testing and Interpreting Tuberculin Skin Results

This information sheet discusses targeted tuberculin testing focusing on the groups at highest risk for latent TB infection (LTBI). It advises that testing should be given to those at highest risk for developing TB, and once TB disease has been ruled out, then it should be offered to those who would benefit from LTBI treatment. It also explains the steps that should be taken to ensure completion of the regimen.

Benh Viêm Gan B

This information sheet explains what hepatitis B is and what chronic hepatitis B is. It explains why Asian and Pacific Islander Americans are at higher risk, the symptoms of chronic hepatitis B, who is at risk for hepatitis B, and how women can protect themselves and their babies from hepatitis B.

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection

This information sheet discusses interferon-gamma release assays (IGRAs), which are whole-blood tests used in diagnosing both latent TB infection and TB disease. It notes that two IGRAs have been approved by the US Food and Drug Administration (FDA) and are commercially available in the United States. The information sheet explains how the IGRAs work; the advantages, disadvantages, and limitations of IGRAs; steps in administering these tests; interpretation; recommendations on when to use them; and whether IGRAs can be given to persons receiving vaccinations.

[Hepatitis A Vaccine: What You Need to Know]

This information sheet discusses the hepatitis A vaccine. It explains hepatitis A virus infection, its effect on the liver, and its transmission and symptoms, and advises that a vaccine can prevent the disease. The information sheet lists who should get the vaccine and when, who should not get the vaccine or should wait, whether there are any risks or adverse reactions to the vaccine, different types of reactions, and what to do. It describes the National Vaccine Injury Compensation Program and provides sources of further information.

Hepatit A Asisi: Bilmeniz Gerekenler

This information sheet discusses the hepatitis A vaccine. It explains hepatitis A virus infection, its effect on the liver, and its transmission and symptoms, and advises that a vaccine can prevent the disease. The information sheet lists who should get the vaccine and when, who should not get the vaccine or should wait, whether there are any risks or adverse reactions to the vaccine, different types of reactions, and what to do. It describes the National Vaccine Injury Compensation Program and provides sources of further information.

TB Elimination: Treatment of Latent Tuberculosis Infection: Maximizing Adherence

This information sheet discusses the need for individuals with latent TB infection (LTBI) to get treatment and prevent the progression of LTBI to TB disease. It emphasizes the importance of the health care provider communicating the value of LTBI treatment and of identifying barriers to adherence. The information sheet also lists strategies for maximizing adherence including collaborating with community agencies and partnering with local health departmetns and community based organizations that can provide needed resources.